Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 0.62 |
| ▸ | TSHR | P16473 | 5/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | CASP1 | P29466 | 1/20 | 0.54 |
| ▸ | CASP7 | P55210 | 1/20 | 0.54 |
| ▸ | RORC | P51449 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26671678 | 1.00 | GAA (0.62) | GAATSHRHSD17B10ALOX15CASP1 | |
| SCHEMBL29793942 | 0.90 | ALDH1A1 (0.49) | GAATSHRHSD17B10ALOX15CASP1 | |
| SCHEMBL26671761 | 0.90 | ALDH1A1 (0.49) | GAATSHRHSD17B10ALOX15CASP1 | |
| SCHEMBL26671713 | 0.90 | GAA (0.66) | GAATSHRHSD17B10ALOX15CASP1 | |
| SCHEMBL29793959 | 0.90 | GAA (0.66) | GAATSHRHSD17B10ALOX15CASP1 | |
| SCHEMBL26671719 | 0.88 | GAA (0.67) | GAATSHRHSD17B10ALOX15CASP1 | |
| SCHEMBL29794034 | 0.85 | GAA (0.72) | GAATSHRHSD17B10ALOX15CASP1 | |
| SCHEMBL29794092 | 0.85 | TSHR (0.70) | GAATSHRHSD17B10ALOX15CASP1 | |
| SCHEMBL26671709 | 0.85 | TSHR (0.70) | GAATSHRHSD17B10ALOX15CASP1 | |
| SCHEMBL26671702 | 0.85 | GAA (0.72) | GAATSHRHSD17B10ALOX15CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250136572-A1 | PARA ACYL SUBSTITUTED DIAZACYCLOHEXENE DERIVATIVES | Renovel Innovations, Inc. (US) | 2025-05-01 | — | — | US | claimed |
| US-20220235004-A1 | PARA ACYL SUBSTITUTED DIAZACYCLOHEXENE DERIVATIVES | Renovel Innovations, Inc. | 2022-07-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220235004-A1 | PARA ACYL SUBSTITUTED DIAZACYCLOHEXENE DERIVATIVES | AADAC, TBXA2R, DPP8 | GAA 1582/4885TSHR 3533/4885HSD17B10 26/4885 |
| US-20250136572-A1 | PARA ACYL SUBSTITUTED DIAZACYCLOHEXENE DERIVATIVES | AADAC, TBXA2R, DPP8 | GAA 1582/4885TSHR 3533/4885HSD17B10 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.